Metadata of CSIR Papers
View Archive Info| Field | Value | |
| Creator |
Vibhuti, A
Arif, E Mishra, A Deepak, D Singh, B Rahman, I Mohammad, G Pasha, MAQ |
|
| Subject |
Medical Laboratory Technology
|
|
| Description |
Background: The genetic susceptibility to chronic obstructive pulmonary disease (COPD) depends on detoxification and antioxidant enzymes, which detoxify cigarette smoke reactive components that, otherwise, generate oxidative stress. Methods: In a case-control study of 346 subjects with and without COPD, we examined the polymorphisms 462Ile/Val, 3801T/C of CYP1A1, -3860G/A of CYP1A2 and -930A/G, 242C/T of CYBA individually or in combination and their contribution to oxidative stress markers by measuring malondialdehyde (MDA), catalase (CAT), glutathione (GSH) and glutathione peroxidase (GPx). Results: COPD patients had significantly increased MDA concentration (p<0.001) and decreased CAT activity, GSH concentration, GPx activity (p <= 0.01). The patients were over-represented by the alleles 462Val, 3801C of CYP1A1 and -9306, 242C of CYBA (p<0.001, p=0.003, p=0.030 and p=0.031, respectively) and consequently the haplotypes of same alleles i.e. 462Va1:3801 C. 462Va1:3801 T and -930G:242C (p = 0.048,p = 0.016 and p = 0.039, respectively). Similarly, CYP1A1 and CYP1A2 haplotypes, 462Va1:3860G and 462Va1:3801T:3860G were significantly over-represented (p=0.001 and p=0.003), respectively in patients. The same alleles-associated genotype-combinations between genes were more prevalent in patients. Of note, the genotypes, 462Ile/Val+Val/Val, 3801TC+CC of CYP1A1 and -930AG+GG of CYBA associated with increased MDA concentration (p=0.018, p = 0.045 and p = 0.017, respectively), decreased CAT activity (p<0.0001. p = 0.080 and p<0.0001, respectively) and GSH concentration (p<0.0001, p=0.0002 and p=0.011, respectively) in patients. Conclusion: The identified alleles, its haplotypes and the genotype-combination along with increased oxidative stress, signify the importance in susceptibility to COPD. (C) 2010 Elsevier B.V. All rights reserved.
|
|
| Publisher |
ELSEVIER SCIENCE BVAMSTERDAMPO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
|
|
| Date |
2011-09-20T12:07:10Z
2011-09-20T12:07:10Z 2010 |
|
| Type |
Article
|
|
| Identifier |
CLINICA CHIMICA ACTA
0009-8981 http://hdl.handle.net/123456789/13134 |
|
| Language |
English
|
|